Ireland
--:--IST
Latest
Clinical Trials in Israel / NCT07707921
Starting soon Not applicable

Pilot Clinical Trial of Ultrasound Guided Aortic Compression for Arresting Abdominal Aortic Blood Flow in Healthy Volunteers. This Isn't Device Feasibility, But Rather the Feasibility of a Clinical Maneuver; Specifically, Evaluating Whether the Technique Can Achieve the Anticipated Out

NCT07707921 · tracked via the Priya Life Science Israel tracker
Phase
Not applicable
Started
2026-08-01
Last updated
2026-07-16

Condition(s) studied

Healthy Volunteers

Investigational drug(s) / intervention(s)

An Ultrasound Guided Aortic Compression for Arresting Abdominal Aortic Blood Flow

An Ultrasound Guided Aortic Compression for Arresting Abdominal Aortic Blood Flow: A second ultrasound device will be used to perform abdominal aortic pressure under vision. A curved probe will be placed on the upper abdomen, above the umbilicus, in the midline position and transverse orientation. The operator will have up to 2 minutes to obtain the desired sonographic view that allows for the compression to begin, with the middle of the probe, the abdominal aorta and the vertebra along the same line. Once the view is obtained, as declared by the operator and confirmed by a member of the study team, time required to obtain this view will be recorded, and recording of the common femoral blood flow will begin (for baseline) for 10 seconds, followed by 30 seconds of compression attempt (of which the compressing ultrasound view will also be recorded synchronously). At the end of the experiment, the participant will be requested to rate their level of discomfort between 0 and 10 (NRS - Numerical Rating Score)

Study summary

As point-of-care ultrasound (POCUS) is becoming more available in the prehospital setting, it can be potentially used for more accurate and directed pressure application, thanks to its ability to image the artery and the underlying bony surface. The investigators therefore aim to conduct a feasibility study on healthy volunteers, to test the efficacy and tolerability of external abdominal compression using an ultrasound probe to obstruct blood flow in the abdominal aorta.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18-40 years. * Informed consent. Exclusion Criteria: * Any known abdominal or vascular pathology. * Any known peripheral neuropathy. * BMI\>30. * Sensitivity to ultrasonic gel. * Tendency for syncope/ pre-syncope during blood-drawing, intravenous cannulation, etc. * Personnel actively serving in the IDF. * Pregnant/ possibly pregnant individuals. * People lacking the ability to give informed consent. * All of the above will be based on subjects' self-reporting. Subjects will be encouraged to consult with their physician.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tel Aviv Medical Center Tel Aviv Tel Aviv

More Tel-Aviv Sourasky Medical Center trials in Israel

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07707921 on ClinicalTrials.gov ↗ ← All trials in Israel